Flagship Ventures Fund V, L.P. 13D and 13G filings for OMEGA THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-31 5:37 pm Sale |
2024-12-29 | 13D | OMEGA THERAPEUTICS INC OMGAQ |
Flagship Ventures Fund V, L.P. | 29,225,579 52.800% |
-19,852 (-0.07%) |
Filing |
| 2023-02-27 5:02 pm Purchase |
2023-02-22 | 13D | OMEGA THERAPEUTICS INC OMGAQ |
Flagship Ventures Fund V, L.P. | 29,245,431 53.200% |
3,343,162 (+12.91%) |
Filing |
| 2021-08-05 6:43 pm Purchase |
2021-08-03 | 13D | OMEGA THERAPEUTICS INC OMGAQ |
Flagship Ventures Fund V, L.P. | 25,902,269 55.400% |
25,902,269 (New Position) |
Filing |